SCHEMBL6651346

SCHEMBL6651346

COC(=O)Oc1c(C(=O)OC2CCCCC2)c2c(c3ccccc13)OC(c1ccc(C)cc1)(c1ccc(C)cc1)C=C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.36
ADORA2B P29275 3/20 0.35
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 5/20 0.31
KDM4E B2RXH2 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
TP53 P04637 1/20 0.31
MAPK1 P28482 3/20 0.30
ALOX15 P16050 2/20 0.30
HSD17B10 Q99714 2/20 0.30
TSHR P16473 3/20 0.30
SMN1; SMN2 Q16637 3/20 0.30
LMNA P02545 2/20 0.30
MAPT P10636 2/20 0.30
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30
KMT2A Q03164 1/20 0.30
MAPK10 P53779 1/20 0.30
POLB P06746 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8978679 0.87 SMN1; SMN2 (0.34) L3MBTL1TDP1ALDH1A1KDM4EMAPK1
SCHEMBL6653402 0.81 L3MBTL1 (0.39) L3MBTL1ADORA2BTDP1ALDH1A1TP53
SCHEMBL6651568 0.81 HTT (0.33) KDM4ETP53HSD17B10TSHRMAPT
SCHEMBL6650625 0.80 MEN1 (0.35) L3MBTL1ALDH1A1KDM4ENPSR1HSD17B10
SCHEMBL6653783 0.79 ALDH1A1 (0.40) L3MBTL1ALDH1A1KDM4ETP53HSD17B10
SCHEMBL10102247 0.78 KLKB1 (0.37) L3MBTL1TDP1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10106951 0.76 ATM (0.39) L3MBTL1TDP1ALDH1A1NPSR1TP53
SCHEMBL13464551 0.76 SMN1; SMN2 (0.38) L3MBTL1TDP1ALDH1A1KDM4ETP53
SCHEMBL10102251 0.75 SMN1; SMN2 (0.37) L3MBTL1TDP1ALDH1A1KDM4ETP53
SCHEMBL17929237 0.75 TSHR (0.36) L3MBTL1ADORA2BTDP1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1248778-B1 SUBSTITUTED PHOTOCHROMIC 2H-NAPHTHO 1,2-B] PYRAN COMPOUNDS PPG IND OHIO INC (US) 2004-06-16 EP claimed
US-6340766-B1 PHOTOCHROMIC DYES ON SUBSTRATES LIKE GLASS WITH PROTECTIVE COATINGS TRANSITION OPTICAL, INC. 2002-01-22 US claimed
US-20020007078-A1 Novel substituted naphthopyrans TRANSITIONS OPTICAL LIMITED (IE) 2002-01-17 US claimed
EP-1248778-B1 SUBSTITUTED PHOTOCHROMIC 2H-NAPHTHO 1,2-B] PYRAN COMPOUNDS PPG IND OHIO INC (US) 2004-06-16 EP disclosed
US-6340766-B1 PHOTOCHROMIC DYES ON SUBSTRATES LIKE GLASS WITH PROTECTIVE COATINGS TRANSITION OPTICAL, INC. 2002-01-22 US disclosed
US-20020007078-A1 Novel substituted naphthopyrans TRANSITIONS OPTICAL LIMITED (IE) 2002-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007078-A1 Novel substituted naphthopyrans CRYZ, NR2E3, UACA L3MBTL1 4785/4885ADORA2B 4289/4885TDP1 2883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.